-
-
-
-
-
-
-
Solid Biosciences Reports Third Quarter 2025 Financial Results and Provides Update on INSPIRE DUCHENNE Clinical Trial Progress and Planned Regulatory Discussions
-
-
-
-
-
-
-
Solid Biosciences (SLDB) Misses Q4 EPS by 100c
-
-
-
-
-
-
-
Solid Biosciences Provides Fourth Quarter and Full-Year 2023 Business Update and Financial Results
-
-
-
-
-
-
-
Solid Biosciences Provides Second Quarter 2022 Business Update and Financial Results
-
-
-
-
-
-
-
Solid Biosciences Provides Third Quarter 2021 Business Update and Financial Results
-
-
-
-
-
-
-
Efficacy and Safety Data from Solid Biosciences’ Ongoing IGNITE DMD Phase I/II Clinical Trial to be Presented at the 2021 MDA Clinical & Scientific Conference
-
-
-
-
-
-
-
Solid Biosciences Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update
-
1,198,644 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

